Search - tctmd.com

Displaying 21 - 40 of 89

Sort: Relevancy | Date

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

Presentation AHA 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presenter: Jeff Healey

November 16, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

VITAL Rhythm Data May Flip the Script on AF Screening in Women

L.A. McKeown

September 08, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

Advertisement

May 2024 Dispatch for the CV Team

April 2024 Dispatch for the CV Team

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

January 2024 Dispatch for the CV Team

AHA Selects 2023’s Leading Cardiovascular Research

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

September 2023 News Roundup

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

August 2023 News Roundup

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

VITAL Rhythm Data May Flip the Script on AF Screening in Women

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

TCTMD’s Top 10 Most Popular Stories for July 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content